Testing and Monitoring During Remission with Vasculitis Sept 2025

Описание: 0:00
2:34 The audience poll on remission
6:49 Oncology definition of remission
10:29 Remission examples
14:55 Considerations for remission
15:44 Monitoring for relapse
24:16 Monitoring for disease complications
27:59 Monitoring for treatment toxicity/complications
33:12 Summary
34:27 Newly diagnosed. How do you know when you are in remission?
37:19 How long does remission usually last?
39:53 What imaging is routinely used for GCA?
41:51 What cancer tests are needed if you were on Cyclophosphamide?
43:31 What should I know about why my liver function test is trending upward when I’m in remission?
46:30 Where is research at with B-Cell therapy?
47:29 Any thoughts on having hip surgery when I’m on prednisone?
51:02 For young children who have GPA (age 14), have you taken the child off all medications when in remission? Do you usually keep them on all medications for longer (Rituximab and Azathioprine )? Wasn’t sure if it’s different for children.
52:04 How can you call it remission if the disease is still requiring immunosuppressives or biologics to keep it under control?
55:20 GPA - once you stop treatment (Rituximab), what is the most common interval for relapse of remission?
56:40 Is there any research being done on how to prolong remission?

Download Dr. Katz's slide presentation: https://tinyurl.com/42j2ckp3

In this webinar, Dr. Guy Katz, rheumatologist and clinician-investigator in the Division of Rheumatology, Allergy, & Immunology at the Massachusetts General Hospital in Boston, discusses which tests should be done and why.